In patients with type 2 diabetes mellitus, decreased levels of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) have been reported to cause hyperglycemia [357]. This evidence concerns the gene GIP and diabetes mellitus.